Syneron Medical Company Profile (NASDAQ:ELOS)

Analyst Ratings

Consensus Ratings for Syneron Medical (NASDAQ:ELOS) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $13.50 (89.34% upside)

Analysts' Ratings History for Syneron Medical (NASDAQ:ELOS)
Show:
DateFirmActionRatingPrice TargetActions
6/16/2016Brean CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/29/2015Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/11/2015Maxim GroupReiterated RatingBuy$18.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/25/2014 forward)

Earnings

Earnings History for Syneron Medical (NASDAQ:ELOS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/19/2016Q116$0.01$0.04$64.38 million$68.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/22/2016Q415$0.07$0.07$75.56 million$78.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/11/2015Q315$0.03$0.03$66.60 million$62.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2015Q215$0.06$0.07$70.93 million$73.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/13/2015Q115$0.01$0.02$62.08 million$63.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/18/2015Q414$0.07$0.09$71.42 million$74.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2014Q314$0.03$0.03$58.32 million$60.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2014Q214$0.07$0.07$63.52 million$64.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/14/2014Q114$0.04$0.04$55.50 million$56.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/20/2014Q413$0.08$0.11$65.70 million$64.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/13/2013Q313$0.01$0.04$62.06 million$62.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/14/2013Q2 2013$0.09$0.02$70.93 million$68.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/22/2013Q1 2013$0.02$0.02$61.19 million$61.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/12/2013Q4 2012$0.09$0.11$70.60 million$72.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2012Q312$0.04$0.03$65.51 million$60.13 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/15/2012$0.04$0.05ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/9/2012$0.04$0.03ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/10/2011($0.09)($0.03)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/11/2011($0.02)($0.01)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/19/2011($0.04)$0.01ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/16/2011($0.04)$0.24ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Syneron Medical (NASDAQ:ELOS)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.00$0.07$0.03
Q2 20162$0.03$0.05$0.04
Q3 20162$0.03$0.04$0.04
Q4 20162$0.09$0.11$0.10
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Syneron Medical (NASDAQ:ELOS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Syneron Medical (NASDAQ:ELOS)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Syneron Medical (NASDAQ:ELOS)
DateHeadline
07/22/16 06:50 AMSyneron Medical Limited Ord (NASDAQ:ELOS) Sellers Covered 33.76% of Their Shorts - Press Telegraph
07/21/16 03:56 PMSyneron Medical Ltd. (ELOS) - Product Pipeline Analysis, 2016 Update - New Study Released
07/20/16 06:38 AMIs $14 Price Target Attainable For Syneron Medical Ltd. (NASDAQ:ELOS)? - Investor Newswire
07/20/16 06:38 AMEquity Roundup: Stock Performance Focus on Syneron Medical Ltd. (NASDAQ:ELOS) - Press Telegraph
07/20/16 06:38 AMSyneron Medical Ltd. (NASDAQ:ELOS) Expected To Post Sales Of $325.583 - Investor Newswire
07/20/16 06:38 AMSyneron Medical Ltd. Realized Volatility Hits Extremely Low Level - CML News
07/20/16 06:38 AMSyneron Medical Ltd (ELOS) Receives FDA Clearance of UltraShape Power - StreetInsider.com
07/19/16 11:20 AMETF’s with exposure to Syneron Medical Ltd. : July 19, 2016 -
07/18/16 03:56 PMFDA OKs Syneron Medical Ltd.’s UltraShape Power Non-Invasive Fat Destruction Device
07/18/16 11:28 AMFDA OKs Syneron Medical Ltd.’s UltraShape Power Non-Invasive Fat Destruction Device - InvestorPlaceInvestorPlace - Stock Market News, Stock Advice & Trading Tips Syneron (ELOS) has announced that its UltraShape Power non-invasive fat destruction device has received approval from the FDA. The post FDA OKs Syneron Medical Ltd.’s UltraShape Power Non-Invasive Fat Destruction Device appeared first on InvestorPlace.
07/18/16 08:52 AMWith Shares Trading up at $7.47 (ELOS) Syneron Candela Announces FDA Clearance…
07/18/16 08:52 AMSyneron Medical Ltd (ELOS) Receives FDA Clearance of UltraShape Power
07/18/16 08:01 AM9:01 am Syneron Medical confirms FDA clearance of its fat destruction device UltraShape Power -
07/18/16 08:00 AMSyneron Candela Announces FDA Clearance of High Energy UltraShape Power for Fat Destruction - [PR Newswire] - WAYLAND, Mass., July 18, 2016 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announces the U.S. Food and Drug Administration (FDA) clearance of its non-invasive ...
07/18/16 07:30 AMSyneron Medical to Report Second Quarter 2016 Financial Results on August 4, 2016 - [PR Newswire] - IRVINE, Calif., July 18, 2016 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced that it will release second quarter 2016 financial results ...
07/17/16 08:19 AMSyneron Medical Ltd. (NASDAQ:ELOS) Broker Price Targets For The Coming Week - Fiscal Standard
07/16/16 07:13 AMCrowd Rating and Earnings Recap for Syneron Medical Ltd. (NASDAQ:ELOS) - Telanagana Press
07/14/16 03:27 PMSyneron Medical Limited Ord (NASDAQ:ELOS) Shorted Shares Decreased By 18.44% - Consumer Eagle
07/14/16 04:20 AMSyneron Medical Ltd. (NASDAQ:ELOS) Wall Street Analyst Recommendation Outlook - Telanagana Press
07/13/16 04:02 PMBroker Outlook For Syneron Medical Ltd. (NASDAQ:ELOS) - Fiscal Standard
07/12/16 08:06 AMTrading Performance and Target Watch for Syneron Medical Ltd. (NASDAQ:ELOS) - Press Telegraph
07/11/16 03:49 PMStrong Sell Calls For Syneron Medical Ltd. (NASDAQ:ELOS) At 0 - Investor Newswire
07/10/16 08:19 AMNext Weeks Broker Price Targets For Syneron Medical Ltd. (NASDAQ:ELOS) - Fiscal Standard
07/08/16 03:49 PMNew Broker Ratings For Syneron Medical Ltd. (NASDAQ:ELOS) - FTSE News
07/07/16 06:43 AMSyneron Medical Ltd. (NASDAQ:ELOS) Current Analyst Ratings - Fiscal Standard
07/04/16 03:32 PMSyneron Medical Ltd. (NASDAQ:ELOS) Expected to Reach Highs Of $14 - Investor Newswire
07/04/16 03:32 PMBroker Outlook For The Week Ahead Syneron Medical Ltd. (NASDAQ:ELOS) - Fiscal Standard
07/01/16 05:10 PMETF’s with exposure to Syneron Medical Ltd. : July 1, 2016 -
06/30/16 07:26 AMSyneron Medical Ltd. (NASDAQ:ELOS) Company Rating and Target Watch - Telanagana Press
06/30/16 07:26 AMSyneron Medical Limited Ord (NASDAQ:ELOS) Sellers Covered 18.44% of Their Shorts - Press Telegraph
06/28/16 08:51 PMSyneron Medical Ltd. (NASDAQ:ELOS) Yearly Sales Target At $325.083 - Investor Newswire
06/28/16 03:47 PMSyneron Medical Ltd. (NASDAQ:ELOS) Earnings Glance and Target Price Review - Engelwood Daily
06/28/16 03:46 PMHow Analysts Rated Syneron Medical Ltd. (NASDAQ:ELOS) Last Week? - Engelwood Daily
06/28/16 03:46 PMStrong Sell Calls Recommendations For Syneron Medical Ltd. (NASDAQ:ELOS) At 0 - Investor Newswire
06/23/16 06:30 AMSyneron Medical Ltd. (NASDAQ:ELOS) Yearly Sales Projections At $325.083 - Investor Newswire
06/23/16 06:30 AMSyneron Medical Ltd. (NASDAQ:ELOS) Stock Momentum at Critical Inflection Point - CML News
06/20/16 03:42 PMSyneron Medical Ltd. (NASDAQ:ELOS) Analyst Price Targets For The Coming Week - Fiscal Standard
06/08/16 02:46 PMSYNERON MEDICAL LTD. (NASDAQ:ELOS) Financial Condition Compared to S&P 500 - CML News
06/03/16 09:59 PMSyneron Medical Ltd. (NASDAQ:ELOS) Do Brokers Advise Buy, Sell Or Hold? - Share Trading News
06/03/16 08:23 AMSyneron Medical Ltd. (ELOS) Stock Rating Reaffirmed by Brean Capital - Let Me Know About This - Syneron Medical Ltd. (ELOS) Stock Rating Reaffirmed by Brean CapitalLet Me Know About ThisSyneron Medical logo Syneron Medical Ltd. (NASDAQ:ELOS)'s stock had its “buy” rating reiterated by research analysts at Brean Capital in a note issued to investors on Tuesday. They presently have a $13.00 price target on the stock. Brean Capital's ...Syneron Medical Ltd. (NASDAQ:ELOS): Price Target ProjectionsNews Tribuneall 2 news articles »
06/02/16 09:53 PMStrong Sell Calls Count For Syneron Medical Ltd. (NASDAQ:ELOS) At 0 - Investor Newswire - Strong Sell Calls Count For Syneron Medical Ltd. (NASDAQ:ELOS) At 0Investor NewswireThe Sell calls on Syneron Medical Ltd. (NASDAQ:ELOS) were 0. Two months earlier 4 were the Strong Buy calls whereas Strong Sell calls were 0. During this period, the hold calls were 0. The buy recommendations were 0 and sell calls count was 0. Analyst ...and more »
06/01/16 08:20 AMStock Review and Earnings Check on Syneron Medical Ltd. (NASDAQ:ELOS) - HNN - Stock Review and Earnings Check on Syneron Medical Ltd. (NASDAQ:ELOS)HNNCurrently, sell-side analysts are expecting Syneron Medical Ltd. (NASDAQ:ELOS) to report quarterly EPS of $0.03. The company's next earnings report is expected to be published on or around 2016-08-02 for the period ending on 2016-06-30. The company ...and more »
05/31/16 03:53 PMBrean Capital Remains Bullish on Syneron Medical Ltd (ELOS) Following UltraShape User Experience in Asia - StreetInsider.com - Brean Capital Remains Bullish on Syneron Medical Ltd (ELOS) Following UltraShape User Experience in AsiaStreetInsider.comBrean Capital maintained a Buy rating and $13.00 price target on Syneron Medical (NASDAQ: ELOS) as the company pushes UltraShape devices into the European and Asian markets. Brean's thesis on Syneron has not changed. It is an under-valued story ...Syneron Medical Ltd. (NASDAQ:ELOS) Quarterly EBIT At $-0.295 MillionsVanguard TribuneSyneron Medical Ltd. (NASDAQ:ELOS) Updated Broker RatingsRisers & FallersAnalysts Bullish on Top Healthcare PicksMarkets.coall 4 news articles »
05/28/16 01:43 PMSyneron Medical Ltd. (NASDAQ:ELOS) Impact Score At 100 - Investor Newswire - Syneron Medical Ltd. (NASDAQ:ELOS) Impact Score At 100Investor NewswireAlpha One explored various online articles released on Syneron Medical Ltd. (NASDAQ:ELOS), and it set a daily sentiment score of 0 on the company. The entity has an algorithm in place to know stock sentiment on the share after exploring the content ...and more »
05/28/16 01:43 PMSyneron Medical Limited Ord (NASDAQ:ELOS) Shorts Decreased by 0.57% After Short Covering - HNN - Syneron Medical Limited Ord (NASDAQ:ELOS) Shorts Decreased by 0.57% After Short CoveringHNNThe stock of Syneron Medical Limited Ord (NASDAQ:ELOS) registered a decrease of 0.57% in short interest. ELOS's total short interest was 623,300 shares in May as published by FINRA. Its down 0.57% from 626,900 shares, reported previously.Syneron Medical Ltd. (NASDAQ:ELOS): Analysts Quick Take on EarningsNews Tribuneall 2 news articles »
05/26/16 01:47 PMRevenue Update on Syneron Medical Ltd.(NASDAQ:ELOS) - Trade Calls - Revenue Update on Syneron Medical Ltd.(NASDAQ:ELOS)Trade CallsSyneron Medical Ltd.(NASDAQ:ELOS) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during Pre-market on May 19, 2016. Company reported revenue of $68.70M. Analysts estimated a revenue of $64.38M. Earnings per ...
05/25/16 01:57 PMEarnings Review and Stock Rundown for Syneron Medical Ltd. (NASDAQ:ELOS) - Wall Street Hints and News - Earnings Review and Stock Rundown for Syneron Medical Ltd. (NASDAQ:ELOS)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting Syneron Medical Ltd. (NASDAQ:ELOS) to ...and more »
05/23/16 04:06 PMETF’s with exposure to Syneron Medical Ltd. : May 23, 2016 -
05/20/16 09:00 AMSyneron Medical Ltd. :ELOS-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/19/16 01:42 PMShare Recap and Earnings Focus on Syneron Medical Ltd. (NASDAQ:ELOS) - Wall Street Hints and News - Share Recap and Earnings Focus on Syneron Medical Ltd. (NASDAQ:ELOS)Wall Street Hints and NewsAnalysts and investors are usually very focused on company earnings numbers when they are released. Company earnings are a good way to evaluate the profitability of the company. Presently, covering analysts are anticipating Syneron Medical Ltd.and more »

Social

About Syneron Medical

Syneron Medical logoSyneron Medical Ltd. is engaged in manufacture, research, development, marketing and sales of advanced equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company designs, develops and markets aesthetic medical products based on its various technologies, including Electro-Optical Synergy (ELOS) technology to provide aesthetic medical treatments. The Company's products targets an array of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, laser-assisted lipolysis and topical skin brightening products.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ELOS
  • CUSIP:
Key Metrics:
  • Previous Close: $7.13
  • 50 Day Moving Average: $7.33
  • 200 Day Moving Average: $7.17
  • P/E Ratio: N/A
  • P/E Growth: 0.74
  • Market Cap: $248.42M
  • Beta: 1.15
  • Current Year EPS Consensus Estimate: $0.27 EPS
  • Next Year EPS Consensus Estimate: $0.51 EPS
Additional Links:
Syneron Medical (NASDAQ:ELOS) Chart for Monday, July, 25, 2016